Skip to main content


Background: Eat, Sleep, Console (ESC) can identify infants experiencing neonatal abstinence syndrome (NAS) and appears to be the better method of assessing the treatment threshold for these infants than the traditional method of Finnegan Neonatal Abstinence Scoring Tool (FNAST). Evidence suggests implementing ESC may decrease length of stay, decrease opioid exposure, and increase use of non-pharmacologic treatment modalities. Problem: In neonates with NAS, utilizing FNAST results in initiation of morphine administration around the clock (ATC) protocol once the infant meets the threshold requirements. FNAST is not a patient-focused model of care. Methods: Retrospective chart review. Inclusion criteria: Infants born greater than or equal to 35 weeks gestational age with a diagnosis of NAS and admitted to Mother-Baby Units, Neonatal Intensive Care Units, and Pediatric Unit. Exclusion criteria: Infants born less than 34.6 weeks gestational age and admission diagnosis that would increase length of stay longer than NAS (ex: sepsis). Conclusion: Implementation of ESC changed the culture of each unit to focus more on non-pharmacologic comfort measures and parental involvement. Overall, ESC implementation decreased LOS by 2.48 days, number of morphine doses administered by 21.56 doses, and total hospital costs by $2,873.70 without increasing 30-day readmission rate.


File nameDate UploadedVisibilityFile size
28 Apr 2023
612 kB



  • Alternative title
    • Eat, Sleep, Console Implementation

  • Subject
    • Nursing

  • Thesis grantor
    • University of North Georgia

  • Degree
    • DNP

  • Date submitted

    28 April 2023

  • Qualification name

    DNP - Nursing Practice

  • Qualification level
    • Doctoral

  • Keywords